✨ Free AI Report
Pulse Biosciences, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Pulse Biosciences, Inc.
Company Research

Pulse Biosciences, Inc.: Business Overview, Financials & Competitive Analysis

Pulse Biosciences is a novel bioelectric medicine company developing proprietary Nanosecond Pulsed Field Ablation (nsPFA) technology for surgical and dermatological applications. The company commercializes the CellFX ...

Analyst-debate audio for Pulse Biosciences, Inc.

AskCyborg analysts argue the bull and bear cases for Pulse Biosciences, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
6/ 10Solid

Cyborg Score thesis

Early-stage bioelectric medicine innovator with unique technology platform and expanding clinical applications seeking path to...

Read the full analyst-debate transcript →
Industry Medical Devices / Bioelectric Medicine / Surgical Equipment
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 14, 2026
AI-Verified Research
30+ Page Report

Get the Latest Pulse Biosciences, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Pulse Biosciences, Inc. Overview

Pro stress-test →

Pulse Biosciences is a novel bioelectric medicine company developing proprietary Nanosecond Pulsed Field Ablation (nsPFA) technology for surgical and dermatological applications. The company commercializes the CellFX System, a multi-application platform that uses nano-pulse electrical energy to non-thermally clear cells while preserving adjacent tissue, addressing unmet clinical needs across multiple therapeutic areas.

Strategic Profile

Pro stress-test →

Positioned as the pioneer in bioelectric medicine with proprietary nsPFA technology that creates a differentiated therapeutic approach. The company employs a utilization-based revenue model with the CellFX platform designed for multi-application expansion from dermatology into cardiac (atrial fibrillation) and other surgical specialties, creating multiple growth vectors.

Competitive Landscape

Pro stress-test →

Pulse Biosciences operates in an emerging bioelectric medicine space with limited direct competitors currently commercializing similar technology. In adjacent markets, the company competes with traditional ablation/surgical device companies (e.g., Hologic, Medtronic) and dermatology device manufacturers in specific applications, though the nsPFA platform's unique mechanism offers differentiation.

Industry Context

Pulse Biosciences, Inc. operates in Medical Devices / Bioelectric Medicine / Surgical Equipment.

Key facts

Founded: 2014 · Headquarters: Miami, Florida · Employees: N/A · Revenue: N/A · Market cap: $1.03B

What the analysts stress-tested

The top findings that survived the multi-agent debate for Pulse Biosciences, Inc..

  • Proprietary nsPFA technology creates a defensible moat in emerging bioelectric medicine category with non-thermal cell clearing capability
  • Multi-application platform strategy (dermatology, cardiac, surgical) diversifies revenue and addresses multiple high-value clinical markets
+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • February 2026Oppenheimer raised price target to $30 from $22
  • February 2026Established new $60 million ATM Program for capital raising
  • +1 moreTrack every material event for Pulse Biosciences, Inc. as it happens. Explore monitoring →
Get alerted when Pulse Biosciences, Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Radiofrequency and Laser Ablation DevicesTraditional thermal ablation technology for surgical and dermatologic applications→Surgical Ablation PlatformsEstablished surgical device leader with cardiac ablation and surgical solutions→Dermatologic Treatment DevicesLaser and light-based dermatology device manufacturer→

Compare Pulse Biosciences, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Pulse Biosciences, Inc. operates in Medical Devices / Bioelectric Medicine / Surgical Equipment. See how the rest of the sector scores on the Cyborg framework.

Browse Medical Devices / Bioelectric Medicine / Surgical Equipment research →
NEW · MCP server

Ask your AI assistant about Pulse Biosciences, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Pulse Biosciences, Inc. and its top competitor on Cyborg Score”
“What did Pulse Biosciences, Inc. do this quarter?”
“Is Pulse Biosciences, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Pulse Biosciences, Inc. do?+
Pulse Biosciences is a novel bioelectric medicine company developing proprietary Nanosecond Pulsed Field Ablation (nsPFA) technology for surgical and dermatological applications. The company commercializes the CellFX ...
What is Pulse Biosciences, Inc.'s Cyborg Score?+
Pulse Biosciences, Inc. has a Cyborg Score of 6/10 (Solid). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Pulse Biosciences, Inc.'s main competitors?+
Named competitors include Radiofrequency and Laser Ablation Devices, Surgical Ablation Platforms, Dermatologic Treatment Devices. The full competitive landscape is in the AskCyborg report.
How can I get the full Pulse Biosciences, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Pulse Biosciences, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Pulse Biosciences, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Medical Devices research

Companies in the same sector and named competitors, ranked by Cyborg Score.

8Ambu A/S6Anika Therapeutics, Inc.6Supermax Corporation Berhad5PolyNovo Limited4Know Labs, Inc.3SeaStar Medical Holding Corporation2Talis Biomedical Corporation